CRO Services


Leveraging Mingqian’s deep expertise in animal model development, the M-CRO Platform delivers a fully integrated, modular system for preclinical drug discovery and evaluation. With extensive mouse model resources, standardized experimental workflows, and robust data analysis capabilities, we offer high-quality, efficient, and customized technical services to research institutes and biopharmaceutical companies.

 

Core Services Include:

• Custom disease model development and validation (e.g., oncology, autoimmune, metabolic, neurological, microbiome)

• Active compound screening and candidate drug evaluation

• Target mechanism studies and biomarker discovery

• Pharmacodynamics (PD) and pharmacokinetics (PK) studies

• Toxicity and safety assessment

• Complex study design including combination therapy, dose-response curves, and multi-timepoint analyses

 

Our platform is supported by advanced laboratory infrastructure, animal handling units, biosample biobanks, and a digital data visualization system—ensuring seamless, end-to-end project execution, from model creation to result delivery.

 

The M-CRO team is composed of industry veterans with strong capabilities in project management and flexible collaboration. We provide a complete service workflow—from study design and experimental execution to data analysis and reporting—tailored to the client’s research stage. Our goal is to help clients accelerate R&D timelines and maximize translational value.